Humacyte Inc (HUMA)
4.41
+0.01
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Humacyte 1 Year Total Returns (Daily): 7.30% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 7.30% |
May 02, 2024 | 14.58% |
May 01, 2024 | 31.34% |
April 30, 2024 | 20.99% |
April 29, 2024 | 26.23% |
April 26, 2024 | 20.18% |
April 25, 2024 | 15.04% |
April 24, 2024 | 12.35% |
April 23, 2024 | 18.73% |
April 22, 2024 | 11.78% |
April 19, 2024 | 10.45% |
April 18, 2024 | 7.48% |
April 17, 2024 | -8.50% |
April 16, 2024 | -5.85% |
April 15, 2024 | -11.69% |
April 12, 2024 | -17.24% |
April 11, 2024 | -19.47% |
April 10, 2024 | -10.21% |
April 09, 2024 | -5.59% |
April 08, 2024 | -3.73% |
April 05, 2024 | 2.70% |
April 04, 2024 | 1.63% |
April 03, 2024 | -2.26% |
April 02, 2024 | -3.88% |
April 01, 2024 | -2.59% |
Date | Value |
---|---|
March 28, 2024 | -2.20% |
March 27, 2024 | -4.32% |
March 26, 2024 | 5.50% |
March 25, 2024 | 7.90% |
March 22, 2024 | 9.60% |
March 21, 2024 | 24.14% |
March 20, 2024 | 30.97% |
March 19, 2024 | 18.71% |
March 18, 2024 | 19.39% |
March 15, 2024 | 13.68% |
March 14, 2024 | 6.04% |
March 13, 2024 | 23.68% |
March 12, 2024 | 21.69% |
March 11, 2024 | 14.34% |
March 08, 2024 | 12.33% |
March 07, 2024 | 1.87% |
March 06, 2024 | 3.69% |
March 05, 2024 | 10.83% |
March 04, 2024 | 12.42% |
March 01, 2024 | 6.23% |
February 29, 2024 | 42.16% |
February 28, 2024 | 43.79% |
February 27, 2024 | 51.00% |
February 26, 2024 | 56.01% |
February 23, 2024 | 42.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.40%
Minimum
Sep 01 2022
56.01%
Maximum
Feb 26 2024
-32.75%
Average
-39.59%
Median
Mar 29 2022
1 Year Total Returns (Daily) Benchmarks
Adial Pharmaceuticals Inc | -77.50% |
Gritstone Bio Inc | -61.18% |
Precision BioSciences Inc | -57.24% |
Puma Biotechnology Inc | 84.79% |
Revance Therapeutics Inc | -88.25% |